Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer
The gBRCA testing should be considered proactively, especially in patients with PC with a family history of HBOC-related cancer.
Authors
- Makiko Urabe (ORCID: https://orcid.org/0009-0009-8033-3158)
- Hiroyuki Uehara (ORCID: https://orcid.org/0000-0003-4064-0179)
- Yugo Kai
- Tazuko Inoue
- Fumie Fujisawa (ORCID: https://orcid.org/0000-0001-8436-9072)
- Ryoji Takada (ORCID: https://orcid.org/0000-0002-6568-8091)
- Takeru Hirao (ORCID: https://orcid.org/0000-0003-4900-4144)
- Takuo Yamai (ORCID: https://orcid.org/0000-0002-5448-4763)
- Kenji Ikezawa (ORCID: https://orcid.org/0000-0001-7517-8960)
- Y. Kawamoto (ORCID: https://orcid.org/0009-0009-1266-6313)
- Kazuyoshi Ohkawa (ORCID: https://orcid.org/0000-0001-9700-2472)
- Yusuke Seiki (ORCID: https://orcid.org/0009-0008-3410-7910)
- Tasuku Nakabori (ORCID: https://orcid.org/0000-0002-9486-850X)
- Ko Watsuji
- Kaori Mukai (ORCID: https://orcid.org/0000-0003-1043-4577)
Institutions
- Osaka Prefectural Medical Center (JP)
- Osaka City General Hospital (JP)
- Osaka International Cancer Institute (JP)
- Osaka International Cancer Institute (JP)
- Shiga Medical Center (JP)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1186/s12885-024-12722-8
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.85